ArticleACS omega2026
Matrix-Aware LC-MS/MS Quantification of Cyhexatin in Chemically Complex Herbal Matrices Using DOE-Assisted Extraction Optimization.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Matrix-dependent analytical interference remains a persistent challenge in LC-MS/MS quantification of hydrophobic pesticides in chemically complex herbal matrices. Cyhexatin, a highly hydrophobic organotin compound, exemplifies this challenge by exhibiting pronounced response variability across matrices under empirically optimized conditions. To address this limitation, we developed a matrix-aware LC-MS/MS workflow combining design-of-experiments (DOE)-assisted extraction optimization with matrix-matched calibration and surrogate internal standard (IS) normalization. Fractional factorial design was first applied to identify influential extraction parameters, followed by Box-Behnken design (BBD) to establish optimal extraction conditions in a representative challenging matrix, Angelicae Gigantis Radix. The optimized method demonstrated robust quantitative performance across Angelicae Gigantis Radix and Paeoniae Radix, satisfying Codex-aligned validation criteria for selectivity, linearity, accuracy, and precision. The method provided low-ppb analytical sensitivity, with limits of detection of approximately 3-4 ppb and a lower limit of quantification of 10 ppb. Notably, DOE-guided optimization improved cyhexatin recovery in the most challenging matrix from approximately 38% under empirical conditions to within the Codex acceptance range (70-120%). Matrix-matched calibration combined with surrogate IS normalization further reduced matrix-dependent signal variability and improved the stability of quantitative responses across matrices. The combined workflow provided robust quantitative performance in the two investigated herbal matrices and illustrated a design-oriented strategy for improving quantitative reliability under matrix-affected LC-MS/MS conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.